BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31184419)

  • 1. Improving survival outcomes of childhood acute lymphoblastic leukemia: A 25-year experience from a single center in Saudi Arabia.
    Jastaniah W
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27782. PubMed ID: 31184419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study.
    Jastaniah W; Al Ghemlas I; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Alsultan A; Abrar MB; Al Sudairy R
    Leuk Res; 2016 Oct; 49():66-72. PubMed ID: 27580158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
    Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
    JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence trends of childhood acute lymphoblastic leukemia in Saudi Arabia: Increasing incidence or competing risks?
    Jastaniah W; Essa MF; Ballourah W; Abosoudah I; Al Daama S; Algiraigri AH; Al Ghemlas I; Alshahrani M; Alsultan A
    Cancer Epidemiol; 2020 Aug; 67():101764. PubMed ID: 32559676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.
    Jaime-Pérez JC; López-Razo ON; García-Arellano G; Pinzón-Uresti MA; Jiménez-Castillo RA; González-Llano O; Gómez-Almaguer D
    Arch Med Res; 2016 Nov; 47(8):668-676. PubMed ID: 28476194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience.
    Al-Nasser A; El-Solh H; De Vol E; El-Hassan I; Alzahrani A; Al-Sudairy R; Al-Mahr M; Al-Musa A; Al-Jefri A; Saleh M; Rifai S; Belgaumi A; Osman L; Ashraf K; Salim M; Silo A; Roberts G
    Ann Saudi Med; 2008; 28(4):251-9. PubMed ID: 18596394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol.
    Vaitkevičienė G; Matuzevičienė R; Stoškus M; Žvirblis T; Ragelienė L; Schmiegelow K
    Medicina (Kaunas); 2014; 50(1):28-36. PubMed ID: 25060202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.
    Jaime-Pérez JC; Jiménez-Castillo RA; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Marfil-Rivera LJ; Gómez-Almaguer D
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic.
    Volejnikova J; Jarosova M; Pospisilova D; Novak Z; Vrbkova J; Hajduch M; Mihal V
    Neoplasma; 2016; 63(3):456-61. PubMed ID: 26925793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results.
    Abboud MR; Ghanem K; Muwakkit S
    Curr Opin Oncol; 2014 Nov; 26(6):650-5. PubMed ID: 25202926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival.
    Abdelmabood S; Fouda AE; Boujettif F; Mansour A
    J Pediatr (Rio J); 2020; 96(1):108-116. PubMed ID: 30240631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study.
    Al-Sudairy R; Al-Nasser A; Alsultan A; Al Ahmari A; Abosoudah I; Al-Hayek R; Al-Harbi T; Al-Manjomi F; Al-Harbi M; Al-Ghamdi H; Al-Shahrani M; Belgaumi AF
    Pediatr Blood Cancer; 2014 Jan; 61(1):74-80. PubMed ID: 23940019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
    Al-Sweedan S; Al-Seraihy A; Al-Ahmari A; Al-Jefri A; Mohammed V; Jafri R; Siddiqui K; Ayas M
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):33-37. PubMed ID: 27906795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
    Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.
    Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC
    Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.
    Suarez A; Piña M; Nichols-Vinueza DX; Lopera J; Rengifo L; Mesa M; Cardenas M; Morrissey L; Veintemilla G; Vizcaino M; Del Toro L; Vicuna V; Fernandez J; Neuberg D; Stevenson K; Gutierrez A
    Pediatr Blood Cancer; 2015 Aug; 62(8):1395-402. PubMed ID: 25808195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience.
    Kairiene I; Pasauliene R; Lipunova N; Vaitkeviciene G; Rageliene L; Rascon J
    Eur J Pediatr; 2017 Oct; 176(10):1329-1337. PubMed ID: 28812191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Outcomes of Childhood Acute Lymphoblastic Leukemia: A Retrospective Single Center Study in Saudi Arabia.
    Ahmed AM; Al-Trabolsi H; Bayoumy M; Abosoudah I; Yassin F
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3391-3398. PubMed ID: 31759364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
    Stiller CA; Draper GJ
    Arch Dis Child; 1989 May; 64(5):657-61. PubMed ID: 2730119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.